Your session is about to expire
← Back to Search
Artificial Intelligence (AI) Activity for High Blood Pressure
N/A
Waitlist Available
Led By Yoshimi Fukuoka, PhD, RN, FAAN
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (run-in period), 4 week-test period, and 3-month intervention period
Awards & highlights
Study Summary
This study is evaluating whether an artificial intelligence intervention can help improve physical activity for individuals with hypertension.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (run-in period), 4 week-test period, and 3-month intervention period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (run-in period), 4 week-test period, and 3-month intervention period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in weekly daily average steps
Duration (minutes) of moderate to vigorous intensity physical activity (MVPA) per day
Secondary outcome measures
Changes in Body Mass Index (BMI)
Changes in Systolic blood pressure (SBP)
Changes in diastolic blood pressure (DBP)
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Artificial Intelligence (AI) Activity groupExperimental Treatment1 Intervention
Participants in this group receive an AI based intervention (automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning and message)
Group II: Control groupActive Control1 Intervention
Participants in this group receive a standardized and fixed 10,000 daily steps goal intervention.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,548 Total Patients Enrolled
Yoshimi Fukuoka, PhD, RN, FAANPrincipal InvestigatorUniversity of California, San Francisco
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger